ArticleJournal of medicinal chemistry2022

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.

Margherita Mastromarino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.